We are live on ! Find out more
CRBU icon

Caribou Biosciences
CRBU

113 hedge funds and large institutions have $457M invested in Caribou Biosciences in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 50 increasing their positions, 24 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

298% more call options, than puts

Call options by funds: $2.17M | Put options by funds: $545K

125% more capital invested

Capital invested by funds: $203M → $457M (+$254M)

108% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 24

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

9.58% more ownership

Funds ownership: 61.5% → 71.08% (+9.6%)

6% less funds holding

Funds holding: 120 → 113 (-7)

33% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 21

Holders
113
Holders Change
-7
Holders Change %
-5.83%
% of All Funds
1.95%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
14
Increased
50
Reduced
24
Closed
21
Calls
$2.17M
Puts
$545K
Net Calls
+$1.62M
Net Calls Change
+$745K

Top Buyers

Rank Fund Capital Flow
1
EWM
Elmwood Wealth Management
California
+$22M
2
State Street
State Street
Massachusetts
+$14.9M
3
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$5.61M
4
Morgan Stanley
Morgan Stanley
New York
+$5.32M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.23M

Top Sellers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
-$12.2M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$2.89M
3
GIM
Granahan Investment Management
Massachusetts
-$1.96M
4
GAA
Green Alpha Advisors
Colorado
-$1.7M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
DFO
26
Duquesne Family Office
New York
$2.86M – – –
IBT
27
International Biotechnology Trust
United Kingdom
$2.72M +$2.39M +256,514 +18,615%
Mirae Asset Global Investments
28
Mirae Asset Global Investments
South Korea
$2.65M +$307K +32,965 +15%
Norges Bank
29
Norges Bank
Norway
$2.6M +$2.3M +246,500 New
GIM
30
Granahan Investment Management
Massachusetts
$2.51M -$1.96M -210,851 -47%
Millennium Management
31
Millennium Management
New York
$2.49M +$1.97M +211,199 +848%
N
32
Nuveen
North Carolina
$2.36M -$293K -31,459 -12%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.91M +$319K +34,286 +23%
Bank of America
34
Bank of America
North Carolina
$1.85M +$954K +102,361 +140%
SCM
35
Shelton Capital Management
Colorado
$1.82M -$85.7K -9,200 -5%
Rafferty Asset Management
36
Rafferty Asset Management
New York
$1.39M +$1.22M +131,239 New
Citigroup
37
Citigroup
New York
$1.36M +$1.07M +114,599 +817%
Swiss National Bank
38
Swiss National Bank
Switzerland
$1.21M – – –
AG
39
Artal Group
Luxembourg
$1.11M – – –
ROTUOC
40
Regents of the University of California
California
$956K -$845K -90,652 -50%
Ensign Peak Advisors
41
Ensign Peak Advisors
Utah
$934K +$167K +17,879 +25%
NCM
42
Nelson Capital Management
California
$897K – – –
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$895K +$79.5K +8,530 +11%
Barclays
44
Barclays
United Kingdom
$880K +$752K +80,692 +2,979%
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$877K +$774K +83,101 New
CRC
46
Curi RMB Capital
Illinois
$789K +$697K +74,787 New
GAA
47
Green Alpha Advisors
Colorado
$732K -$1.7M -182,896 -72%
SAM
48
Stansberry Asset Management
Texas
$714K -$15.6K -1,676 -2%
BG
49
Bellevue Group
Switzerland
$699K -$37.3K -4,000 -6%
LFCM
50
Long Focus Capital Management
Puerto Rico
$686K -$140K -15,000 -19%
1
2
3 4 5

CRBU Hedge Fund Activity: Q3 2022 in Review

113 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q3 2022, worth a combined $457M — up 125% from $203M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of CRBU and 14 opened new positions — a net loss of 7 holders — while 24 trimmed existing stakes and 50 added.

The largest buyer was Elmwood Wealth Management, opening a new position worth an estimated $22M. The largest seller was Farallon Capital Management, cutting an estimated $12.2M.

  • 113 institutional investors held Caribou Biosciences (CRBU) as of Q3 2022, down from 120 in Q2 2022.
  • Funds reported $457M of Caribou Biosciences stock for Q3 2022, up 125% quarter-over-quarter.
  • 14 funds opened new Caribou Biosciences positions in Q3 2022 and 21 closed out, a net change of -7 holders.
  • The largest Caribou Biosciences buyer in Q3 2022 was Elmwood Wealth Management, an estimated $22M added.
  • The largest Caribou Biosciences seller in Q3 2022 was Farallon Capital Management, an estimated $12.2M sold.

Based on aggregated 13F filings for Q3 2022.